Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Gains from Investment Securities (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Gains from Investment Securities for 4 consecutive years, with $468000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $468000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $694000.0 through Dec 2025, up 265.26% year-over-year, with the annual reading at $5.7 million for FY2024, 28.34% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $468000.0 at Orchestra BioMed Holdings, down from $682365.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $5.7 million in Q1 2025, with the low at -$36000.0 in Q3 2022.
  • Average Gains from Investment Securities over 4 years is $1.6 million, with a median of $575182.5 recorded in 2025.
  • The sharpest move saw Gains from Investment Securities soared 4808.95% in 2023, then tumbled 97.23% in 2024.
  • Over 4 years, Gains from Investment Securities stood at $226000.0 in 2022, then soared by 650.1% to $1.7 million in 2023, then soared by 217.2% to $5.4 million in 2024, then tumbled by 91.3% to $468000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $468000.0, $682365.0, and $5.7 million for Q4 2025, Q2 2025, and Q1 2025 respectively.